Přehled o publikaci
2024
Genotype is associated with left ventricular reverse remodelling and early events in recent-onset dilated cardiomyopathy
KUBANEK, Milos; Jana BINOVA; Lenka PIHEROVA; Alice KREBSOVA; Martin KOTRC et. al.Basic information
Original name
Genotype is associated with left ventricular reverse remodelling and early events in recent-onset dilated cardiomyopathy
Authors
KUBANEK, Milos; Jana BINOVA; Lenka PIHEROVA; Alice KREBSOVA; Martin KOTRC; Hana HARTMANNOVA; Katerina HODANOVA; Dita MUSALKOVA; Viktor STRANECKY; Tomas PALECEK; Anna CHALOUPKA; Ilga GROCHOVA; Jan KREJČÍ; Jana PETRKOVA; Vojtech MELENOVSKY; Stanislav KMOCH and Josef KAUTZNER
Edition
ESC Heart Failure, SAN FRANCISCO, Sons Ltd, 2024, 2055-5822
Other information
Language
English
Type of outcome
Article in a journal
Country of publisher
United States of America
Confidentiality degree
is not subject to a state or trade secret
References:
Organization
Lékařská fakulta – Repository – Repository
UT WoS
001288249100001
EID Scopus
2-s2.0-85200972427
Keywords in English
Genetics; Left ventricular reverse remodelling; Prognosis; Recent-onset dilated cardiomyopathy; Whole-exome sequencing
Links
LM2018132, research and development project. LX22NPO5104, research and development project.
Changed: 31/1/2025 00:50, RNDr. Daniel Jakubík
Abstract
V originále
gt;= 10% relative decrease. Median follow-up was 41 months. RODCM was familial in 98 (25%) individuals. Class 4-5 variants of interest (VOIs) were identified in 125 (32%) cases, with 69 (18%) having a single titin-truncating variant (TTNtv) and 56 (14%) having non-titin (non-TTN) VOIs. The presence of class 4-5 non-TTN VOIs, but not of TTNtv, heralded a lower probability of 12-month LVRR and proved to be an independent baseline predictor both of the primary and the secondary outcome. The negative result of genetic testing was a strong protective baseline variable against occurrence of life-threatening ventricular arrhythmias. Detection of class 4-5 VOIs in genes coding nuclear envelope proteins was another independent predictor of both study outcomes at baseline and also of life-threatening ventricular arrhythmias after 12 months. Class 4-5 VOIs of genes coding cytoskeleton were associated with an increased risk of life-threatening ventricular arrhythmias after baseline assessment. A positive family history of dilated cardiomyopathy alone only related to a lower probability of LVRR at 12 months and at the final follow-up. ConclusionsRODCM patients harbouring class 4-5 non-TTN VOIs are at higher risk of progressive heart failure and life-threatening ventricular arrhythmias. Genotyping may improve their early risk stratification at baseline assessment.